Carol Davila University acquires the Quest building for the Institute for Research and Development in Genomics

Carol Davila University has completed the purchase of the Quest boutique building, located in central-eastern Bucharest. The transaction was brokered by Crosspoint Real Estate, a Savills associate in Romania.

The acquisition of this modern building, built last year, represents a significant step in achieving the long-term goals of the Institute for Research and Development in Genomics (ICDG). This will allow the development of the laboratories necessary to carry out and derive value from basic and applied research activities in the field of omic sciences. The building, with a GBA of 4,500 square meters, has state-of-the-art spaces and will be designed to house the national genomics infrastructure, thus strengthening the position of the “Carol Davila” University of Medicine and Pharmacy in the field of medical research in Romania.

The building has 8 floors and two underground levels offering 38 parking spaces. It was chosen following a rigorous assessment process that involved strict requirements for the architectural design and state-of-the-art technical equipment necessary for genomics research.

“It is with immense satisfaction and pride that we announce the completion of the purchase of Quest builting, an important step in the development of the Institute for Research and Development in Genomics. This purchase represents not only a physical expansion of our campus, but also an expansion of the scientific and medical horizons of Romania. The building will house state-of-the-art laboratories and research spaces, thus contributing to the advancement of research in genomics, bioinformatics and other omic sciences. It will also allow the academic community to participate in high-level research projects using a well-equipped infrastructure. Given the global context in which we find ourselves, when medical and scientific research are more important than ever, this investment underlines the continuous commitment of “Carol Davila” University to be at the forefront of knowledge and innovation. We are confident that this new acquisition will have a significantly positive impact on the quality of research and healthcare in Romania and abroad.

In closing, I would like to thank everyone involved in this ambitious project, including our administrative team and of course the academic community for their continued support. Together, we are building a better and healthier future for everyone.”, said the Rector of the “Carol Davila” University of Medicine and Pharmacy, Viorel Jinga, PhD.